Back

Statin and glucose-lowering treatment in individuals with and without schizophrenia

1 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Neuro and psychiatric Psychiatric Disorders and Heart Disease ESC Premium Access ESC Congress 2019

About the speaker

Photo
Associate Professor Sven V Eriksson

Hospital Enkoping Medical Center, Enkoping (Sweden)

8 More presentations in this session

Presentation thumbnail
Doctor L. Bastagli (Bologna, IT)
Abstract Slides
Presentation thumbnail
Doctor G. Vanerio (Montevideo, UY)
Abstract Slides
Presentation thumbnail
Associate Professor S. Yildiz (Istanbul, TR)
Abstract Slides
Presentation thumbnail
Mr R. Abdullah (Oslo, NO)
Abstract
Presentation thumbnail
Professor J. Barth (Haarlem, NL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Neuro and psychiatric

The Event

Event poster

ESC Congress 2019

1 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Acute myocardial infarction in several mental illness: a nationwide analysis of prevalence, management strategies and outcomes
29 August 2020
thumbnail
Congress Presentation
Empagliflozin use versus dipeptidyl peptidase 4 inhibitors reduces risk of cardiovascular and renal disease among type 2 diabetes patients in routine care in europe and israel: EMPRISE study results
29 June 2021
thumbnail
Congress Presentation
Statin adherence in coronary outpatients: a novel direct method compared with pharmacy registry data
26 April 2024
thumbnail
Congress Presentation
Updated treatment thresholds in the 2019 ESC/EAS dyslipidaemia guidelines substantially expand indications for statin use for primary prevention at population level: results from the Rotterdam Study
30 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources